Drug Company To Pay $24M To Settle Claims In Securities Class Action Suit
CHICAGO — Pharmaceutical company Akorn Inc. has agreed to pay $24 million to settle claims that it and certain of its current and former executive officers misrepresented the company’s financial results...To view the full article, register now.
Already a subscriber? Click here to view full article